Who invested in Recursion Pharmaceuticals

8 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$339Mraised across 8 rounds since 2014, from 8 sources

$130KSeed$170KSeed$830KDebt$1.5MGrant$13MSeries A$2.1MSeries A$121MSeries C$200MRound

Latest round: Round, $200MJun 2024
Step-upi: 1.7×
Investors: 7

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201420162018202020222024

$130KSeed$170KSeed$830KDebt$13MSeries A$2.1MSeries A$121MSeries C$200MRound

First round: Seed, $130K
Biggest round: $200M
Usual gap between rounds: 19 months

The rounds

Jun 2024
Round$200M4 new2 returning
Source recorded
Jul 2019
Series C$121M
No investor was named in the report.
Reported by HealthtechpulseSEC filing: $122M sold, first sale Feb 2019
Nov 2016
Series A$2.1M1 new
- Felicis
Reported by FinSMEsSEC filing: $15M sold, first sale Sept 2016
Oct 2016
Series A$13M1 new
- Lux Capital
Reported by FinSMEsSEC filing: $4.1M sold, first sale Sept 2016
Feb 2015
Grant$1.5M1 new
- National Institutes of Health
From a historical funding recordSEC filing: $830K sold, first sale Feb 2015
Feb 2015
Debt$830K
No investor was named in the report.
From a historical funding recordSEC filing: $830K sold, first sale Feb 2015
Aug 2014
Seed$170K
No investor was named in the report.
From a historical funding record
Jan 2014
Seed$130K
No investor was named in the report.
From a historical funding recordSEC filing: $80K sold, first sale Mar 2014

Founders and team

From Recursion Pharmaceuticals's own website and the SEC filings it signed: 5 on the team.

Ben TaylorChief Financial Officer & President Recursion UK
Erica FoxChief People and Impact Officer
Ryan KellyChief Communications Officer
Christopher C. GibsonExecutive Officer, Director, Promoteri
Michael Martin SecoraExecutive Officer, Promoteri

On the board, as filediBlake C. BorgesonDean C. LiR. Martin ChavezRobert C. HershbergTerry-Ann C. BurrellZachary C. BogueZavain C. Dar

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2014Seed2014Debt2015Grant2015Series A2016Series A2016Series C2019Round2024

Felicis

Lux Capital

Menlo Ventures

National Institutes of HealthNVIDIA

Obvious Ventures

Catalio Capital Management

Everyone who backed them

FelicisVC firm2rounds

Lux CapitalVC firm2rounds

Menlo VenturesVC firm1round

National Institutes of HealthGovernment1round

NVIDIACompany1round

Obvious VenturesAccelerator1round

Catalio Capital ManagementVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 5 firms list Recursion Pharmaceuticals as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.